Идентичност

Dalilesen Impurity 5

Не е посочено · C23H23ClN6O3

01Идентичност

Lazychem IDLC-36211
CAS RNНе е посочено
PubChem CID118127062
Molecular formulaC23H23ClN6O3
Molecular weight466.9 g/mol
IUPAC name[5-chloro-2-(triazol-2-yl)phenyl]-[(2S)-2-(5,6-dimethoxy-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]methanone
InChIKeyWRTMDRWKXMIWFX-QHCPKHFHSA-N

02Структура и стереохимия

Two-dimensional chemical structure of Dalilesen Impurity 5
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count5
Secondary amines0
Tertiary amines0
SMILESC[C@]1(CCCN1C(=O)C2=C(C=CC(=C2)Cl)N3N=CC=N3)C4=NC5=CC(=C(C=C5N4)OC)OC
InChIНе е посочено

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Статус в Индия

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Имена и връзки

API и изходно лекарство

Не е посочено

Имена и връзки

    06Източници